Clinical Trials in San Antonio

Showing 1761-1780 of 7,028 trials

Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study

NCT05797896

An observational study to investigate the natural history and evaluate biomarkers of participants with geographic atrophy secondary to age-related macular degeneration

Complement Therapeutics250 participantsStarted Feb 2023

Glendale, California, United States • Mountain View, California, United States • Carmel, Indiana, United States +19 more locations

COMPLETEDPhase 3< 1 mile

Tapinarof for the Treatment of Plaque Psoriasis in Adults (3001)

NCT03956355

This is a randomized, double-blind, vehicle-controlled Phase 3 study to evaluate the efficacy and safety of topical tapinarof cream, 1% once daily for the treatment of plaque psoriasis in adults. Approximately 500 adult subjects with plaque psoriasis will be randomized 2:1 to receive either tapinarof cream, 1% or matching vehicle cream once daily for 12 weeks.

Plaque Psoriasis

Organon and Co510 participantsStarted May 2019

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Hot Springs, Arkansas, United States +50 more locations

Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study

Tapinarof for the Treatment of Plaque Psoriasis in Adults (3001)

Find Trials by Condition in San Antonio

AVID100 in Advanced Epithelial Carcinomas

A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough

A Study to Evaluate the Efficacy and Safety of Gantenerumab in Participants at Risk for or at the Earliest Stages of Alzheimer's Disease (AD)

A Study Evaluating the Safety, Tolerability, and Efficacy of EVO756 in Adults With Chronic Inducible Urticaria

Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer

Study of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological Malignancies

Saroglitazar Magnesium for Treatment of Primary Biliary Cholangitis

DETECT-RPC Universal EM Screening

A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS)

Shared-Decision Making for Hydroxyurea

A Study to Investigate Efficacy and Safety of VTAMA (Tapinarof) Cream, 1% in Intertriginous Plaque Psoriasis

A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor Treatment

Long-Term Safety and Antibody Persistence of TDV and the Impact of a Booster Dose

A Follow-On Study of Donanemab (LY3002813) With Video Assessments in Participants With Alzheimer's Disease (TRAILBLAZER-EXT)

Study of Long Term Safety and Clinical Outcomes of Idursulfase IT and Elaprase Treatment in Pediatric Participants Who Have Completed Study HGT-HIT-094

A Study of TAK-079 in Adults With Persistent/Chronic Primary Immune Thrombocytopenia

The Role of Electrophysiology Testing in Survivors of Unexplained Cardiac Arrest

Open-Label Study of the CDK4/6 Inhibitor SPH4336 in Subjects With Locally Advanced or Metastatic Liposarcomas